Patents for A61P 35 - Antineoplastic agents (221,099)
11/2011
11/24/2011CA2800065A1 Reagents and methods for treating cancer
11/24/2011CA2800015A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
11/24/2011CA2799989A1 Polycyclic quinazolines, preparation thereof, and use thereof
11/24/2011CA2799944A1 Methods and compositions related to modulating autophagy
11/24/2011CA2799773A1 Novel self-reactive arms and prodrugs comprising same
11/24/2011CA2799764A1 Mtor selective kinase inhibitors
11/24/2011CA2799579A1 Chemical compounds, compositions and methods for kinase modulation
11/24/2011CA2799480A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
11/24/2011CA2799202A1 Compositions and methods for treatment of autoimmune and other diseases
11/24/2011CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/24/2011CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo
11/24/2011CA2791951A1 Biological materials related to her3
11/23/2011EP2388330A1 Liver engrafting cells, assays, and uses thereof
11/23/2011EP2388320A1 Anti-hs6st2 antibody and use thereof
11/23/2011EP2388315A2 Use of a combination of myxoma virus and rapamycin for therapeutic treatment
11/23/2011EP2388275A2 An aglycosylated IgG1 antibody to CD3
11/23/2011EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
11/23/2011EP2388259A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
11/23/2011EP2388255A1 Polysubstituted benzofurans and medicinal applications thereof
11/23/2011EP2388014A1 Therapeutic application of tumoral immunoglobulin variable region peptides in patients with B-cell malignancies
11/23/2011EP2388005A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
11/23/2011EP2387609A2 Non-embryonic stem cells and uses thereof
11/23/2011EP2387572A2 Protein kinase c inhibitors and uses thereof
11/23/2011EP2387563A1 Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl]oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer
11/23/2011EP2387560A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/23/2011EP2387559A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/23/2011EP2387421A1 Compounds comprising n-formyl-methionine residues and tumor-targeting peptides
11/23/2011EP2387405A2 Pirenzepine as an agent in cancer treatment
11/23/2011EP2387401A1 Method for treating colorectal cancer
11/23/2011EP2387316A1 Fused amino pyridines for the treatment of brain tumors
11/23/2011EP2260033B1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
11/23/2011EP2107906B1 Novel therapeutic use for treating leukaemia
11/23/2011EP2035391B1 Indazole derivatives for treating hsp90-induced diseases
11/23/2011EP2020996B1 Method and compositions for treating hematological malignancies
11/23/2011EP2007732B1 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
11/23/2011EP1951674B1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
11/23/2011EP1866319B1 Phosphono-pent-2-en-1-yl nucleosides and analogs
11/23/2011EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
11/23/2011EP1765328B1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
11/23/2011EP1735277B1 2-alkylidene-18,19-dinor-vitamin d compounds
11/23/2011EP1727558B1 Use of dmbt1 for capturing sulphate and phosphate group exposing agents
11/23/2011EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011EP1391451B1 2-iminopyrrolidine derivates
11/23/2011EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation
11/23/2011EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins
11/23/2011CN202048757U Freeze dryer used for freeze-drying Cordyceps sinensis
11/23/2011CN1671351B NSAID-containing topical formulations that demonstrate chemopreventive activity
11/23/2011CN102257138A Tumor antigen peptide and use thereof
11/23/2011CN102257008A Antibodies against human angiopoietin 2
11/23/2011CN102256989A Anionic conjugates of glycosylated bacterial metabolite
11/23/2011CN102256980A 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives
11/23/2011CN102256972A Thiazolyl-benzimidazoles
11/23/2011CN102256943A Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid
11/23/2011CN102256623A Neuroinvasion inhibitor
11/23/2011CN102256616A Combination therapy with peptide epoxyketones
11/23/2011CN102256603A Inhibitors of mitosis for increasing apoptosis in therapy
11/23/2011CN102251013A Antibody and antigen for recognizing tumor initiator cell and application thereof
11/23/2011CN102250918A Recombinant human interferon-like proteins
11/23/2011CN102250904A Medicine for preventing and/or treating melanoma
11/23/2011CN102250852A Clone and expression of bovine recombinant alpha-1,3-galactoside transferase (GT)
11/23/2011CN102250735A Propolis wine combined with golden camellia and preparation method thereof
11/23/2011CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof
11/23/2011CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof
11/23/2011CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound
11/23/2011CN102250277A Macromolecular polymer capable of carrying medicine and used for embolism
11/23/2011CN102250260A Enzyme engineering manufacturing method of functional glycan
11/23/2011CN102250254A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) fusion protein, its preparation and applications
11/23/2011CN102250252A Gastrin-releasing peptide (GRP) guided fusion protein
11/23/2011CN102250250A Human-mouse chimeric anti-human CD19 antibody Hm2E8b and use thereof
11/23/2011CN102250249A Anti-VEGF/PDGFR (Vascular Endothelial Growth Factor/Platelet-Derived Growth Factor Receptor) beta double-specificity antibody and application thereof
11/23/2011CN102250248A Anti-VEGF/ANG2 bispecific antibody, and application thereof
11/23/2011CN102250247A Bispecific antibody to VEGF/ANG2 and application thereof
11/23/2011CN102250246A Bispecific antibody to VEGF/PDGFR beta and application thereof
11/23/2011CN102250245A Bispecific antibody capable of resisting B cell lymphoma and application thereof
11/23/2011CN102250244A Human prolactin receptor antibody and application thereof
11/23/2011CN102250223A Molecular improved apoptin (30-121) as well as preparation method and application thereof
11/23/2011CN102250211A HLA-A*3303-Restricted WT1 Peptide and pharmaceutical composition comprising the same
11/23/2011CN102250210A Human plasminogen Kringle 5 short peptide, its pharmaceutical composition, application and polynucleotide encoding the short peptide
11/23/2011CN102250209A Novel HLA-A2 (Human Leukocyte Antigen-Alpha2) restrictive epitope polypeptide and application thereof
11/23/2011CN102250208A New HLA-A2 restrictive epitope polypeptide and application thereof
11/23/2011CN102250207A Novel human leukocyte antigen (HLA)-A2 limiting epitope polypeptide and use thereof
11/23/2011CN102250206A New HLA-A2 restrictive epitope polypeptide and application thereof
11/23/2011CN102250205A Preparation method of fatty acyl-RGD (Arg Gly Asp) induced docetaxel target liposome and antitumor activity thereof
11/23/2011CN102250203A Beta-carboline aminoacid benzyl ester, preparation method and application thereof
11/23/2011CN102250202A 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof
11/23/2011CN102250190A Oleanolic saponin derivative, preparation method of salt thereof and application of derivative
11/23/2011CN102250189A Glycyrrhetic acid derivative with 1, 12-diene-3-ketone skeleton, its preparation method and medicinal uses
11/23/2011CN102250188A Ursolic acid series medicament with anti-inflammatory and anti-tumor activity and preparation thereof
11/23/2011CN102250179A Stable protein kinase activator, and preparation method and purpose thereof
11/23/2011CN102250176A Antitumor antibiotic ancomycin and its derivative
11/23/2011CN102250150A Organic hydridized tetra-core platinum complex and preparation method thereof as well as application technology field of complex in antitumor medicament preparation
11/23/2011CN102250149A Ionic iridium coordination compounds having weak coordinate bonds and preparation method and use thereof
11/23/2011CN102250143A Imidazole benzamide compounds and application thereof in preparation of anti-malignant tumor medicaments
11/23/2011CN102250138A Germatrane compound as well as preparation method and application thereof
11/23/2011CN102250110A Magnesium cantharidate and preparation method thereof
11/23/2011CN102250109A Phenol compounds as well as preparation method and application thereof
11/23/2011CN102250106A Extraction method of sesquiterpene lactone compound from Chinese mugwort leaf and application thereof
11/23/2011CN102250105A Camptothecin derivatives, synthesis method thereof and use thereof